Welcome to LookChem.com Sign In|Join Free

CAS

  • or

467-13-0

Post Buying Request

467-13-0 Suppliers

Recommended suppliersmore

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

467-13-0 Usage

Chemical Properties

Brown Solid

Uses

Different sources of media describe the Uses of 467-13-0 differently. You can refer to the following data:
1. A metabolite of Codeine. Controlled substance
2. A metabolite of Codeine (C634075). Controlled substance.

Check Digit Verification of cas no

The CAS Registry Mumber 467-13-0 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 4,6 and 7 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 467-13:
(5*4)+(4*6)+(3*7)+(2*1)+(1*3)=70
70 % 10 = 0
So 467-13-0 is a valid CAS Registry Number.
InChI:InChI=1/C18H19NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-12,17H,7-9H2,1-2H3/t11-,12+,17-,18-/m0/s1

467-13-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name codeinone

1.2 Other means of identification

Product number -
Other names 6-Oxocodeine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:467-13-0 SDS

467-13-0Relevant articles and documents

Combined biological and chemical catalysis in the preparation of oxycodone

Walker, Adam J.,Bruce, Neil C.

, p. 561 - 568 (2004)

The opioid oxycodone was produced from codeine, using a combination of chemical and biological catalysis. The use of novel functionalized ionic liquids permitted this reaction to be performed in a single solvent.

-

Findlay,Small

, p. 4001,4004 (1951)

-

-

Fleischhacker,W.,Markut,H.

, p. 569 - 586 (1971)

-

Transformation of codeine and codeine-6-glucuronide to opioid analogues by urine adulteration with pyridinium chlorochromate: Potential issue for urine drug testing

Luong, Susan,Ung, Alison T.,Kalman, John,Fu, Shanlin

, p. 1609 - 1620 (2014)

Rationale: Pyridinium chlorochromate (PCC) is the active ingredient of 'Urine Luck', a commercially available in vitro adulterating agent used to conceal the presence of drugs in a urine specimen. The exposure of codeine and its major glucuronide metabolite codeine-6-glucuronide (C6G) to PCC was investigated to determine whether PCC is an effective masking agent for these opiate compounds. Methods: Following the addition of PCC to both spiked and authentic codeine and C6G-positive urine specimens, the samples were monitored using liquid chromatography/mass spectrometry (LC/MS). Stable reaction products were identified and characterized using high-resolution MS analysis and, where possible, nuclear magnetic resonance (NMR) analysis. Results: It was determined that PCC effectively oxidizes codeine and C6G, thus altering the original codeine-to-C6G ratio in the urine specimen. Four reaction products were identified for codeine: codeinone, 14-hydroxycodeinone, 6-O-methylcodeine and 8-hydroxy-7,8-dihydrocodeinone. Similarly, three reaction products were identified for C6G: codeinone, codeine and a lactone of C6G (tentative assignment). Conclusions: Besides addressing the complications added to interpretation, more investigation is warranted to further determine their potential for use as markers for monitoring the presence of codeine and C6G in urine specimens adulterated with PCC. Copyright

Compositions and Methods For Making Alkaloid Morphinans

-

Paragraph 0051; 0236-0238, (2017/09/30)

Methods that may be used for the manufacture of a class of chemical compounds known as morphinans, including neopine, are provided. Compositions useful for the synthesis of morphinans, including neopine, are also provided.